Ireland -
English -
HPRA (Health Products Regulatory Authority)
reminyl
shire pharmaceuticals limited - galantamine hydrobromide - oral solution - 4 mg/ml - galantamine
Ireland -
English -
HPRA (Health Products Regulatory Authority)
reminyl xl
shire pharmaceuticals limited - galantamine hydrobromide - capsules hard - 16 milligram - galantamine
Ireland -
English -
HPRA (Health Products Regulatory Authority)
reminyl xl
shire pharmaceuticals limited - galantamine - capsules hard - 24 milligram - galantamine
Ireland -
English -
HPRA (Health Products Regulatory Authority)
reminyl xl
shire pharmaceuticals limited - galantamine hydrobromide - capsules hard - 8 milligram - galantamine
Ireland -
English -
HPRA (Health Products Regulatory Authority)
reminyl 4 milligram film coated tablet
shire pharmaceuticals limited - galantamine hydrobromide - film coated tablet - 4 milligram - anticholinesterases
Ireland -
English -
HPRA (Health Products Regulatory Authority)
reminyl 12 milligram film coated tablet
shire pharmaceuticals limited - galantamine hydrobromide - film coated tablet - 12 milligram - anticholinesterases
Ireland -
English -
HPRA (Health Products Regulatory Authority)
reminyl 8 milligram film coated tablet
shire pharmaceuticals limited - galantamine hydrobromide - film coated tablet - 8 milligram - anticholinesterases
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
reminyl 4mg tablets
shire pharmaceuticals ltd - galantamine hydrobromide - oral tablet - 4mg
Ireland -
English -
HPRA (Health Products Regulatory Authority)
tyvense 20 milligram capsules hard
shire pharmaceutical contracts ltd - lisdexamfetamine dimesylate - capsules hard - 20 milligram - phenylethylamine derivatives - centrally acting sympathomimetics - it is indicated as part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (adhd) in children aged 6 years and over when response to previous methylphenidate treatment is considered clinically inadequate
Ireland -
English -
HPRA (Health Products Regulatory Authority)
tyvense 40 milligram capsules hard
shire pharmaceutical contracts ltd - lisdexamfetamine dimesylate - capsules hard - 40 milligram - phenylethylamine derivatives - centrally acting sympathomimetics - it is indicated as part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (adhd) in children aged 6 years and over when response to previous methylphenidate treatment is considered clinically inadequate